[uschat 49th-icaac 416 300]
To ask a question of the panel via Twitter use the hash tag #ICAAC
The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) is the annual infectious diseases meeting of the American Society for Microbiology. This show will broadcast the daily press conferences for the 49th ICAAC being held September 12-14, 2009 at San Francisco's Moscone Center.
Please note: The following schedule is preliminary and subject to change. Listed participants are invited, not confirmed.
Saturday, September 12
WATCH VIDEO 9:00 a.m. PST -- Controversies in Managing MRSA Infections: To Screen or Not to Screen?
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a major cause of hospital-acquired infections, and these infections can often be difficult and expensive to treat. One strategy to reduce MRSA infection rates in the healthcare setting is the screening of patients for nasal or throat colonization and isolating patients to control spread of the bacteria. Many states have already enacted laws mandating screening of certain patients. Do these policies actually help reduce the incidence of disease or do they just drive up healthcare costs? Presenters in this press conference will discuss the latest research on both sides of this issue.
WATCH VIDEO 9:45a.m. PST – MRSA in West Coast Beaches.
Lance Peterson, NorthShore University HealthSystem, Evanston, IL, United States
- John Boyce, Hospital of Saint Raphael, New Haven, CT, United States
Researchers report the first isolation of MRSA from marine and beach sand samples taken from numerous public beaches in Washington State. Participants will present their findings and discuss the implications.
WATCH VIDEO 12:00 noon PST -- Opening Briefing.
Marilyn C. Roberts, University of Washington, Seattle, WA, United States
Olusegun O. Soge, University of Washington, Seattle, WA, United States
Members of the ICAAC Program Committee will give an overview of the ICAAC meeting and discuss sessions of particular interest.
Scott Hammer, Columbia University, New York, NY
M. Lindsay Grayson, Austin Hospital/Austin Health, Melbourne, Australia
Karen Bush, Johnson & Johnson Pharmaceutical R&D, Raritan, NJ
Sunday, September 13
WATCH VIDEO 8:30 a.m PST -- H1N1 Influenza Update. The emergence of the H1N1 influenza virus earlier this year has put the world on notice for the next influenza pandemic. Participants in this press conference will provide an overview of the current H1N1 situation and discuss recent advances concerning antiviral resistance, influenza-bacteria interactions and vaccines.
- Nancy Cox, Ph.D., Director, Influenza Division, U.S. Centers for Disease Control
- Jonathon McCullers, Associate Member, Associate Member, Dept. of Infectious Disease, St. Jude Children's Research Hospital
WATCH VIDEO 10:00 a.m. PST -- Tuberculosis: A Zoonosis? Traditionally, tuberculosis has been viewed as a primarily human disease. Recent studies have found other sources of Mycobacterium tuberculosis among animal populations including elephants, meerkats, dogs and baboons. A related bacterium that can also cause disease in humans, M. bovis, is running rampant in cattle in parts of Africa. Given these findings, scientists are beginning to approach tuberculosis not just as a disease of humans but a zoonosis (a disease transmitted between humans and animals). Participants will present approaches for monitoring the disease in zoological parks and in the wild as well as research suggesting for the first time that M. tuberculosis can infect cattle after all.
WATCH VIDEO 11:00 a.m. PST – Emerging Infectious Diseases.
Glyn Hewinson, Veterinary Laboratories Agency, Weybridge, Addlestone,, , United Kingdom
Michelle Miller, Palm Beach Zoo, West Palm Beach, FL, United States
- Paul van Helden, University of Stellenbosch, Tygerberg, South Africa
The infectious disease landscape is constantly changing. As we develop treatments for and work to eradicate existing diseases, invariably new ones arise to take their place and sometimes old ones resurge. Public health researcher Kenrad Nelson, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, discusses the the rise of hepatitis E and its potential to spread via organ transplants.
WATCH VIDEO 12:00 noon PST – New Issues in the Control of C. difficile
- Kenrad Nelson, Johns Hopkins Bloomberg Sch. of Public Health, Baltimore, MD, United States
. Clostridium difficile bacteria are a common cause of antibiotic-associated diarrhea, especially in hospital settings. According to the Centers for Disease Control and Prevention, each year in the United States C. difficile is responsible for tens of thousands of cases of diarrhea and at least 5,000 deaths. New research on how this infection is transmitted suggest that symptomatic patients can aerosolize infective spores and that these spores can be found on surfaces throughout patients’ hospital room and not just on the patients themselves. Participants will present this research as well as discuss the impact of these findings on future control efforts against this infection.
Curtis Donskey, VA Med. Ctr., Cleveland, OH, United States
John Boyce, Hospital of Saint Raphael, New Haven, CT, United States
Dubert M. Guerrero, Case Western Reserve University, Cleveland, OH, United States
Monday, September 14
WATCH VIDEO 8:30 a.m. PST – Latebreaking Influenza Research.
The latest research on H1N1 influenza taken from our latebreaker slide abstracts, including the synergistic effect of a combination of three influenza drugs against drug-resistant virus, and a finding that patients are still infective over a week after initial symptoms appear, suggesting the recommended self-quarantine period is not enough.
WATCH VIDEO 10:00 a.m. PST – Infections in the Wars in Afghanistan and Iraq.
Amy Patick, Adamas Pharmaceuticals, Emeryville, CA, United States
- Gaston De Serres, Associate Professor, Laval University, Quebec, Canada
The wars in Iraq and Afghanistan are giving rise to new challenges to the infectious disease community. Soldiers fighting in those countries are acquiring infections that are not normally seen by doctors in the United States. Participants will discuss these foreign infections and the challenges they present.
David Aronoff, University of Michigan, Ann Arbor, MI, United States
Clinton Murray, Brooke Army Medical Ctr, Fort Sam Houston, TX, United States
WATCH VIDEO 11:00 a.m. PST -- Rhinovirus: Beyond the Common Cold. Rhinovirus is typically viewed as the cause of the common cold, but that is not the only disease it can cause. Participants will present the latest research on the effects of rhinovirus beyond a cold including its potential role in asthma, new and emerging rhinoviruses around the world and promising treatments for rhinovirus infection that have yet to make it to market and why.
Ian Mackay, SASVRC, Royal Children's Hospital, Brisbane, Queensland, Australia
Nathan Bartlett, Imperial Coll., London, , United Kingdom
Ronald Turner, University of Virginia, Charlottesville, VA, United States